In this Eye to Eye, hear how the pathology of endophthalmitis affects vitreoretinal surgeons. The novel adjuvant therapeutics now in development will be discussed and the future direction of endophthalmitis research examined.
Jan van Meurs MD, vitreoretinal surgeon at the Rotterdam Eye Hospital, the Netherlands talks with Michelle Callegan PhD, Director of Vision Research, Department of Ophthalmology, Dean McGee Eye Institute, Oklahoma, USA